Senzime AB (publ) (SEZI.ST)

SEK 5.64

(-1.05%)

Total Liabilities Summary of Senzime AB (publ)

  • Senzime AB (publ)'s latest annual total liabilities in 2023 was 58.06 Million SEK , down -4.46% from previous year.
  • Senzime AB (publ)'s latest quarterly total liabilities in 2024 Q2 was 73.5 Million SEK , up 29.24% from previous quarter.
  • Senzime AB (publ) reported annual total liabilities of 60.77 Million SEK in 2022, up 152.8% from previous year.
  • Senzime AB (publ) reported annual total liabilities of 24.04 Million SEK in 2021, down -12.72% from previous year.
  • Senzime AB (publ) reported quarterly total liabilities of 73.5 Million SEK for 2024 Q2, up 29.24% from previous quarter.
  • Senzime AB (publ) reported quarterly total liabilities of 58.06 Million SEK for 2023 FY, down -4.46% from previous quarter.

Annual Total Liabilities Chart of Senzime AB (publ) (2023 - 2008)

Historical Annual Total Liabilities of Senzime AB (publ) (2023 - 2008)

Year Total Liabilities Total Liabilities Growth
2023 58.06 Million SEK -4.46%
2022 60.77 Million SEK 152.8%
2021 24.04 Million SEK -12.72%
2020 27.54 Million SEK 14.45%
2019 24.06 Million SEK -19.1%
2018 29.74 Million SEK 16.33%
2017 25.57 Million SEK 4.63%
2016 24.44 Million SEK 1126.44%
2015 1.99 Million SEK -10.94%
2014 2.23 Million SEK 91.47%
2013 1.16 Million SEK -6.29%
2012 1.24 Million SEK -67.12%
2011 3.79 Million SEK -5.82%
2010 4.02 Million SEK -11.76%
2009 4.56 Million SEK -5.42%
2008 4.82 Million SEK 0.0%

Peer Total Liabilities Comparison of Senzime AB (publ)

Name Total Liabilities Total Liabilities Difference
Acarix AB (publ) 10.99 Million SEK -427.96%
ADDvise Group AB (publ) 2.67 Billion SEK 97.829%
ADDvise Group AB (publ) 2.67 Billion SEK 97.829%
Arcoma AB 33.3 Million SEK -74.343%
Bactiguard Holding AB (publ) 329.7 Million SEK 82.389%
BICO Group AB (publ) 3.26 Billion SEK 98.221%
Boule Diagnostics AB (publ) 279.9 Million SEK 79.255%
CellaVision AB (publ) 212.32 Million SEK 72.653%
Clinical Laserthermia Systems AB (publ) 14.19 Million SEK -308.995%
Chordate Medical Holding AB (publ) 6.86 Million SEK -745.327%
C-Rad AB (publ) 122.4 Million SEK 52.561%
Duearity AB (publ) 17.53 Million SEK -231.232%
Dignitana AB (publ) 37.56 Million SEK -54.564%
Episurf Medical AB (publ) 19.8 Million SEK -193.258%
Getinge AB (publ) 24.69 Billion SEK 99.765%
Scandinavian Real Heart AB (Publ) 20.6 Million SEK -181.865%
Iconovo AB (publ) 14.55 Million SEK -298.965%
Integrum AB (publ) 22.07 Million SEK -163.061%
Luxbright AB (publ) 7 Million SEK -729.486%
Mentice AB (publ) 163.55 Million SEK 64.498%
OssDsign AB (publ) 105.25 Million SEK 44.835%
Paxman AB (publ) 44.5 Million SEK -30.457%
Promimic AB (publ) 16.15 Million SEK -259.402%
Qlife Holding AB (publ) 62.16 Million SEK 6.601%
SciBase Holding AB (publ) 21.27 Million SEK -172.887%
ScandiDos AB (publ) 37.18 Million SEK -56.147%
Sectra AB (publ) 1.64 Billion SEK 96.462%
Sedana Medical AB (publ) 44.06 Million SEK -31.78%
SpectraCure AB (publ) 14.97 Million SEK -287.746%
Stille AB 172.64 Million SEK 66.366%
Vitrolife AB (publ) 3.66 Billion SEK 98.417%
Xvivo Perfusion AB (publ) 250.56 Million SEK 76.826%